Richard Christopher
Overview
Richard Christopher received an average of $629K in total compensation, including $345K in salary, at InVivo Therapeutics Holdings from 2019 to 2022. Richard Christopher also received an average of $373K at ICAD between 2016 and 2017.
- 2022
- 2021
- 2020
- 2019
- 2017
- 2016
InVivo Therapeutics HoldingsChief Financial Officer
InVivo Therapeutics HoldingsChief Financial Officer
InVivo Therapeutics HoldingsChief Financial Officer
InVivo Therapeutics HoldingsChief Financial Officer
ICADChief Financial Officer
ICADChief Financial Officer
Source: SEC filings on December 5, 2023, August 18, 2022, May 18, 2021, June 22, 2020, November 20, 2018, and October 20, 2017.
Related executives
We found 29 more executives who work or worked at InVivo Therapeutics Holdings and ICAD.
Dana Brown
ICAD
Chief Executive Officer
Stacey Stevens
ICAD
Chief Executive Officer
Jonathan Go
ICAD
Chief Technology Officer
Eric Lonnqvist
ICAD
Chief Financial Officer
Richard Toselli
InVivo Therapeutics Holdings
Chief Executive Officer
Heather Hamel
InVivo Therapeutics Holdings
Chief Legal Officer
Charles Carter
ICAD
Chief Financial Officer
Michael Klein
ICAD
Chief Executive Officer
News
InVivo Therapeutics Holdings CEO Richard Toselli's 2022 pay slips 11% to $960K
December 5, 2023
InVivo Therapeutics Holdings CEO Richard Toselli's 2021 pay jumps 30% to $1.1M
August 18, 2022
InVivo Therapeutics Holdings CEO Richard Toselli's 2020 pay falls 34% to $832K
May 18, 2021
InVivo Therapeutics Holdings CEO Richard Toselli's 2019 pay jumps 69% to $1.3M
June 22, 2020